For research use only ยท Not for human or animal consumption
// Growth Hormone & Endocrine

Ipamorelin Research Guide

A synthetic pentapeptide ghrelin receptor agonist described in 1998 as the first selective growth hormone secretagogue. Covers the pharmacology, animal and clinical studies.

5Sources
3FAQs
4Min read
For research use only. Not for human consumption.
01

What is Ipamorelin?

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2. It came out of a chemistry program as one of a series of compounds lacking the central Ala-Trp dipeptide of growth hormone-releasing peptide-1 (GHRP-1), and was described in 1998 as the first selective growth hormone secretagogue (Raun et al., 1998).

It acts at the ghrelin receptor (Beck et al., 2014), which separates it from GHRH analogues such as tesamorelin.

02

Research areas studied

The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.

Pharmacology and selectivity

In primary rat pituitary cells, ipamorelin released growth hormone with potency and efficacy similar to GHRP-6, and antagonist studies showed it acts through a GHRP-like receptor. In swine, none of the secretagogues tested changed FSH, LH, prolactin or TSH. Unlike GHRP-6 and GHRP-2, ipamorelin did not raise ACTH or cortisol, even at doses far above those needed for growth hormone release (Raun et al., 1998).

Animal studies

In adult female rats given ipamorelin for 15 days, longitudinal bone growth rate and body weight gain increased in a dose-dependent way, while total IGF-I levels and serum markers of bone formation and resorption did not change (Johansen et al., 1999).

Published human research

A pharmacokinetic and pharmacodynamic study in healthy male volunteers reported a short terminal half-life of about 2 hours and a single episode of growth hormone release after each infusion, peaking at about 40 minutes (Gobburu et al., 1999). A phase 2 randomized trial in 117 patients after bowel resection found it was well tolerated but showed no significant differences from placebo on the key efficacy endpoint, time to a tolerated solid meal (Beck et al., 2014).

Regulatory status

Ipamorelin is not an approved drug in the sources reviewed. FDA’s compounding safety page placed ipamorelin acetate in category 2 for 503B outsourcing facilities on September 29, 2023, citing possible immunogenicity and other concerns. Human data are limited to short studies, and the one efficacy trial did not meet its key endpoint.

03

Storage and handling

Like most research peptides, Ipamorelin is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.

When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.

04

Quality and COA

Every Zero Zero Collection product page has a View COA link. Certificates of analysis come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page where available. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.

05

Ipamorelin FAQ

What makes ipamorelin "selective"?

In the original pharmacology study, it released growth hormone without raising ACTH or cortisol, unlike the comparison secretagogues GHRP-6 and GHRP-2.

Which receptor does ipamorelin act on?

It is a ghrelin receptor agonist, acting through what the original study called a GHRP-like receptor.

Is ipamorelin an approved drug?

No. It is not approved in the sources reviewed, and FDA placed ipamorelin acetate in category 2 for 503B outsourcing facilities in 2023.

07

References

  1. Raun K, Hansen BS, Johansen NL, et al. (1998). Eur J Endocrinol. PubMed 9849822
  2. Johansen PB, Nowak J, Skjaerbaek C, et al. (1999). Growth Horm IGF Res. PubMed 10373343
  3. Gobburu JV, Agersรธ H, Jusko WJ, et al. (1999). Pharm Res. PubMed 10496658
  4. Beck DE, Sweeney WB, McCarter MD, et al. (2014). Int J Colorectal Dis. PubMed 25331030
  5. U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 28, 2026. fda.gov

For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.

Get 15% Off Your First Order

Join the Zero Zero Collection list for restock alerts, new COAs and member pricing. Research use only.